Evaluation of Efficacy and Safety Profile of Intense Pulsed Light Treatment in Melasma in Darker Skin Type

1. Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin. 2007;25(3):343-52.10.1016/j.det.2007.05.00417662900Search in Google Scholar

2. Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P, et al. A global survey of the role of ultra-violet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23(11):1254-62.10.1111/j.1468-3083.2009.03295.x19486232Search in Google Scholar

3. Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatol Venereol. 2010;24(11):1312-6.10.1111/j.1468-3083.2010.03638.x20337826Search in Google Scholar

4. Roberts WE. Pollution as a risk factor for the development of melasma and other skin disorders of facial hyperpigmentation - is there a case to be made? J Drugs Dermatol. 2015;14(4):337-41.Search in Google Scholar

5. Lee DB, Suh HS, Choi YS. A comparative study of lowfluence 1,064 nm Q-Switched Nd: YAG laser with or without chemical peeling using Jessner’s solution in melasma patients. J Cosmet Laser Ther. 2014;16(6):264-70.10.3109/14764172.2013.86420124245978Search in Google Scholar

6. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q‐switched ruby laser. J Dermatol Surg Oncol. 1994;20(9):592-7.10.1111/j.1524-4725.1994.tb00152.x8089359Search in Google Scholar

7. Moreno Arias GA, Ferrando J. Intense pulsed light for melanocytic lesions. Dermatol Surg. 2001;27(4):397-400.10.1046/j.1524-4725.2001.00315.x11298715Search in Google Scholar

8. Wang CC, Hui CY, Sue YM, Wong WR, Hong HS. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg. 2004;30(9):1196-200.Search in Google Scholar

9. Jutley GS, Rajaratnam R, Halpern J, Salim A, Emmett C. Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review. J Am Acad Dermatol. 2014;70(2):369-73.10.1016/j.jaad.2013.07.04424438951Search in Google Scholar

10. Chan R, Park KC, Lee MH, Lee ES, Chang SE, Leow YH, et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0· 01%, hydroquinone 4%, tretinoin 0· 05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159(3):697-703.Search in Google Scholar

11. Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther. 1996;276(2):765-9.Search in Google Scholar

12. Monteiro RC, Kishore BN, Bhat RM, Sukumar D, Martis J, Ganesh HK. A comparative study of the efficacy of 4% hydroquinone vs 0.75% Kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 2013;58(2):157.10.4103/0019-5154.108070365722723716817Search in Google Scholar

13. Wu S, Shi H, Wu H, Yan S, Guo J, Sun Y, et al. Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg. 2012;36(4):964-70.10.1007/s00266-012-9899-922552446Search in Google Scholar

14. Karn D, Kc S, Amatya A, Razouria EA, Timalsina M. Oral tranexamic acid for the treatment of melasma. Kathmandu Univ Med J (KUMJ). 2012;10(4):40-3.10.3126/kumj.v10i4.1099323575051Search in Google Scholar

15. Grover C, Reddu BS. The therapeutic value of glycolic acid peels in dermatology. Indian J Dermatol Venereol Leprol. 2003;69(2):148-50.Search in Google Scholar

16. Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol. 2010;76(4):447.10.4103/0378-6323.6660220657143Search in Google Scholar

17. Wattanakrai P, Mornchan R, Eimpunth S. Low‐fluence Q‐switched neodymium‐doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010;36(1):76-87.10.1111/j.1524-4725.2009.01383.x20298254Search in Google Scholar

18. Manaloto RM, Alster T. Erbium: YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25(2):121-3.10.1046/j.1524-4725.1999.08103.x10037517Search in Google Scholar

19. Lee HS, Won CH, Lee DH, An JS, Chang HW, Lee JH, et al. Treatment of melasma in Asian skin using a fractional 1,550-nm laser: an open clinical study. Dermatol Surg. 2009;35(10):1499-504.10.1111/j.1524-4725.2009.01264.x19674038Search in Google Scholar

20. Tamega Ade A, Miot LD, Bonfietti C, Gige TC, Marques ME, Miot HA. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013;27(2):151-6.10.1111/j.1468-3083.2011.04430.x22212073Search in Google Scholar

21. Lutfi RJ, Fridmanis M, Misiunas AL, Pafume O, Gonzalez EA, Villemur JA, et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab. 1985;61(1):28-31.10.1210/jcem-61-1-283923030Search in Google Scholar

22. Zoccali G, Piccolo D, Allegra P, Giuliani M. Melasma treated with intense pulsed light. Aesthetic Plast Surg. 2010;34(4):486-93.10.1007/s00266-010-9485-y20225000Search in Google Scholar